UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER

SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION

OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-52864

 

Entia Biosciences, Inc .

(Exact name of registrant as specified in its charter)

 

13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, Oregon

(971) 228-0709

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

 

Common Stock

(Title of each class of securities covered by this form.)

 

                                                                               

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) ☐
  Rule 12g-4(a)(2) ☒
  Rule 12h-3(b)(1)(i) ☐
  Rule 12h-3(b)(1)(ii) ☒
  Rule 15d-6 ☐
  Rule 15d-22(b) ☐

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Entia Biosciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: November 30, 2018                                                     By:       /s/ Timothy A. Timmins                     

Timothy A. Timmins

President and Chief Executive Officer

 

 

 

Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counselor by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 

SEC 2069 (08-11)

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

 

Entia Biosciences (CE) (USOTC:ERGO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Entia Biosciences (CE) Charts.
Entia Biosciences (CE) (USOTC:ERGO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Entia Biosciences (CE) Charts.